Staphylococcus colonization of the skin and antimicrobial peptides.
Staphylococci are the most abundant skin-colonizing bacteria and the most important causes of nosocomial infections and community-associated skin infections. Molecular determinants of staphylococcal skin colonization include surface polymers and proteins that promote adhesion and aggregation, and a wide variety of mechanisms to evade acquired and innate host defenses. Antimicrobial peptides (AMPs) likely play a central role in providing immunity to bacterial colonization on human epithelia. Recent research has shown that staphylococci have a broad arsenal to combat AMP activity, and can regulate expression of AMP-resistance mechanisms depending on the presence of AMPs. While direct in vivo evidence is still lacking, this suggests that the interplay between AMPs and AMP resistance mechanisms during evolution had a crucial role in rendering staphylococci efficient colonizers of human skin.
Otto
Michael
M
National Institute of Allergy and Infectious Diseases, NIH, 9000 Rockville Pike, Building 33 1W10, Bethesda, MD 20892, USA, Tel.: +1 301 443 5209.
FEMS Microbiol Lett. 1989 Apr;49(2-3):263-7
2765032
Epidemiol Infect. 1995 Aug;115(1):51-60
7641838
Cell Microbiol. 2004 Mar;6(3):269-75
14764110
J Biol Chem. 1999 Mar 26;274(13):8405-10
10085071
J Exp Med. 1999 Mar 15;189(6):907-18
10075974
Curr Pharm Biotechnol. 2009 Jan;10(1):2-18
19149587
J Vet Med Sci. 2002 Mar;64(3):245-50
11999444
FEMS Immunol Med Microbiol. 1999 Apr;23(4):289-93
10225288
Contrib Microbiol. 2009;16:136-149
19494583
Clin Infect Dis. 1998 May;26(5):1182-7
9597250
Arch Dermatol. 1977 Jun;113(6):780-2
141239
Peptides. 2001 Oct;22(10):1643-50
11587792
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9469-74
17517597
Antimicrob Agents Chemother. 2006 Aug;50(8):2608-20
16870749
Methods Mol Biol. 2008;431:241-54
18287761
Appl Environ Microbiol. 2008 Oct;74(19):6155-7
18689520
Annu Rev Immunol. 1995;13:61-92
7612236
Appl Microbiol. 1975 Sep;30(3):381-5
810086
Infect Immun. 1999 Aug;67(8):4268-71
10417203
Br J Dermatol. 1974 May;90(5):525-30
4601016
J Immunol. 2004 Jan 15;172(2):1169-76
14707093
Res Microbiol. 2001 Apr-May;152(3-4):351-6
11421282
J Invest Dermatol. 2004 Sep;123(3):522-9
15304092
Bacteriol Rev. 1963 Mar;27:56-71
14000926
Crit Rev Microbiol. 1999;25(3):155-72
10524328
Mol Microbiol. 2005 Mar;55(6):1883-95
15752207
J Bacteriol. 2007 Apr;189(7):2793-804
17277069
J Immunol. 2003 Sep 15;171(6):3262-9
12960356
Peptides. 2005 Feb;26(2):217-25
15629533
J Infect Dis. 1980 Oct;142(4):510-5
7192302
Regul Pept. 2003 Apr 15;112(1-3):147-52
12667636
Antonie Van Leeuwenhoek. 1996 Feb;69(2):151-9
8775975
J Biol Chem. 1997 May 16;272(20):13088-93
9148921
Annu Rev Microbiol. 2001;55:165-99
11544353
Science. 1999 Jul 30;285(5428):760-3
10427003
J Clin Invest. 2003 May;111(9):1265-73
12727914
Microbes Infect. 2002 Apr;4(4):481-9
11932199
J Bacteriol. 1992 Apr;174(8):2711-6
1556089
J Bacteriol. 2005 Apr;187(7):2426-38
15774886
J Antimicrob Chemother. 2009 Jul;64(1):9-15
19451132
Emerg Infect Dis. 2001 Mar-Apr;7(2):178-82
11294701
Mol Immunol. 2003 Nov;40(7):457-62
14568392
J Bacteriol. 1996 Jan;178(2):531-6
8550476
Antimicrob Agents Chemother (Bethesda). 1968;8:442-4
5735390
J Biol Chem. 1995 Jun 30;270(26):15598-606
7797557
Clin Sci (Lond). 2006 Jan;110(1):21-35
16336202
J Biol Chem. 2000 Mar 31;275(13):9876-81
10734144
J Infect Dis. 2009 Mar 1;199(5):625-32
19199541
Science. 1969 Aug 1;165(3892):454-65
4893486
Infect Immun. 2006 Aug;74(8):4598-604
16861647
J Appl Bacteriol. 1985 Jan;58(1):45-55
3980296
Infection. 2008 Aug;36(4):314-21
18648747
Mol Microbiol. 2007 Dec;66(5):1136-47
17961141
FEMS Microbiol Lett. 1998 Sep 15;166(2):203-11
9770275
Annu Rev Microbiol. 1994;48:585-617
7826020
J Leukoc Biol. 2005 Apr;77(4):476-86
15629886
Clin Infect Dis. 2001 May 15;32 Suppl 2:S114-32
11320452
FEBS Lett. 1998 Mar 6;424(1-2):89-94
9537521
Nat Rev Microbiol. 2006 Jul;4(7):529-36
16778838
J Bacteriol. 2008 Jun;190(11):3835-50
18375547
Arch Microbiol. 1989;152(1):16-9
2764678
Nucleic Acids Res. 2003 Jan 15;31(2):602-7
12527768
J Leukoc Biol. 2004 Jan;75(1):39-48
12960280
Infect Disord Drug Targets. 2008 Sep;8(3):135-43
18782030
Microbes Infect. 2006 Jul;8(8):2195-205
16797202
Biochem J. 1988 May 15;252(1):87-93
3138972
J Bacteriol. 1996 Jan;178(1):175-83
8550413
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6573-8
11997460
J Exp Med. 2001 May 7;193(9):1067-76
11342591
Science. 1999 Oct 15;286(5439):525-8
10521347
J Leukoc Biol. 2001 May;69(5):691-7
11358975
Antimicrob Agents Chemother. 2005 Apr;49(4):1465-7
15793127
J Biosci Bioeng. 2004;98(6):429-36
16233732
N Engl J Med. 1998 Aug 20;339(8):520-32
9709046
FEMS Immunol Med Microbiol. 2008 Oct;54(1):137-43
18665847
Nat Rev Microbiol. 2009 Aug;7(8):555-67
19609257
J Immunol. 2003 Mar 1;170(5):2274-8
12594247
Chem Immunol Allergy. 2005;86:22-41
15976486
Immunology. 2007 Sep;122(1):80-9
17472720
J Immunol. 2004 Jan 15;172(2):1146-56
14707090
Br J Dermatol. 2004 Sep;151(3):534-9
15377337
Trends Microbiol. 1998 Dec;6(12):484-8
10036727
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1218-23
9990004
Infection. 2005 Feb;33(1):3-8
15750752
FEBS Lett. 2005 Mar 28;579(9):1917-22
15792796
J Immunol. 2004 Sep 1;173(5):2909-12
15322146
Trends Microbiol. 2000 Sep;8(9):402-10
10989307
Front Biosci. 2004 Jan 01;9:841-63
14766414
Curr Protein Pept Sci. 2008 Feb;9(1):39-49
18336322
Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):195-9
7529412
Antimicrob Agents Chemother. 1982 Aug;22(2):277-83
6821457
J Exp Med. 2000 Oct 2;192(7):1069-74
11015447
J Clin Microbiol. 1989 Jan;27(1):78-81
2913039
Science. 2006 Feb 24;311(5764):1113-6
16497924
Clin Sci (Lond). 1996 Jul;91(1):3-16
8774254
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19456-61
19047636
Biosci Biotechnol Biochem. 2004 Aug;68(8):1663-71
15322349
Trends Microbiol. 2005 Dec;13(12):596-601
16242332
J Immunol. 2005 Jun 15;174(12):8003-10
15944307
J Biol Chem. 2004 Dec 24;279(52):54881-6
15501828
J Invest Dermatol. 2008 Jul;128(7):1863-6
18200058
FEBS Lett. 1995 Jul 10;368(1):173-6
7615076
Lancet Infect Dis. 2005 Dec;5(12):751-62
16310147
Trends Microbiol. 2002 Apr;10(4):179-86
11912025
Blood. 2000 Nov 1;96(9):3086-93
11049988
Clin Microbiol Rev. 2000 Jan;13(1):16-34, table of contents
10627489
Nature. 1988 May 19;333(6170):276-8
2835685
Cell Mol Life Sci. 2007 Apr;64(7-8):922-33
17310278
Mol Microbiol. 2005 Feb;55(3):778-87
15661003
Antimicrob Agents Chemother. 2004 Jan;48(1):285-96
14693553
J Invest Dermatol. 2002 Nov;119(5):1090-5
12445197
Br Med J. 1959 Jan 31;1(5117):270-3
13618615
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12055-9
8618843
Infect Immun. 1997 Jan;65(1):95-100
8975897
Infect Immun. 2009 Sep;77(9):3978-91
19581398
Infect Immun. 1999 Oct;67(10):5001-6
10496870
Antonie Van Leeuwenhoek. 1996 Feb;69(2):119-127
8775972
Infect Dis Clin North Am. 2009 Mar;23(1):17-34
19135914
FASEB J. 2006 Jan;20(1):35-42
16394265
Microbiol Rev. 1995 Jun;59(2):171-200
7603408
Kidney Int. 2005 Mar;67(3):1084-92
15698449
Nat Immunol. 2005 Jan;6(1):57-64
15568027
Cell Mol Life Sci. 2008 Aug;65(16):2450-60
18661101
Curr Top Microbiol Immunol. 2008;322:207-28
18453278
J Biol Chem. 2001 Feb 23;276(8):5707-13
11085990
Ann N Y Acad Sci. 1974 Jul 31;236(0):252-66
4278611
Protein Eng. 1995 Mar;8(3):315-8
7479693
Nat Immunol. 2001 Dec;2(12):1133-7
11694882
JAMA. 2007 Oct 17;298(15):1763-71
17940231
Science. 1997 Jun 27;276(5321):2027-30
9197262
Lancet Infect Dis. 2002 Mar;2(3):180-9
11944188
Biochim Biophys Acta. 2006 Sep;1758(9):1408-25
16716248
Lancet. 2006 Mar 4;367(9512):731-9
16517273
Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9
15561843
Microbes Infect. 2003 Nov;5(14):1317-27
14613775
Biosci Rep. 1993 Aug;13(4):245-50
8305635
N Engl J Med. 2002 Oct 10;347(15):1151-60
12374875
Mol Microbiol. 2007 Jan;63(2):497-506
17176256
FEBS Lett. 1999 Jun 11;452(3):309-13
10386612
Antimicrob Agents Chemother (Bethesda). 1963;161:667-70
14274980
Nature. 2002 Jan 24;415(6870):389-95
11807545
Nature. 2001 Nov 22;414(6862):454-7
11719807
N Engl J Med. 2001 Jan 4;344(1):11-6
11136954
FEBS Lett. 1999 May 7;450(3):257-62
10359085
Infect Control Hosp Epidemiol. 2009 Jul;30(7):633-5
19496651
Nat Rev Microbiol. 2005 Dec;3(12):948-58
16322743
Science. 2008 Feb 15;319(5865):962-5
18276893
Lancet. 1989 Feb 18;1(8634):390
2563548
Annu Rev Biochem. 1973;42:91-112
4147186
Antimicrob Agents Chemother. 2009 Apr;53(4):1598-609
19164152
Ann Hum Biol. 1976 May;3(3):221-7
962302
Lancet. 2004 Aug 21-27;364(9435):703-5
15325835
Am J Infect Control. 2004 Dec;32(8):470-85
15573054
Appl Environ Microbiol. 2003 Jan;69(1):18-23
12513972
Nat Med. 2007 Dec;13(12):1510-4
17994102
Nat Rev Immunol. 2003 Sep;3(9):710-20
12949495
Eur J Biochem. 1995 Jun 1;230(2):587-600
7607233
Cell. 2005 Aug 12;122(3):461-72
16096064
Infect Immun. 1997 Feb;65(2):519-24
9009307
J Invest Dermatol. 2001 Nov;117(5):1120-5
11710922
J Immunol. 2005 Mar 1;174(5):2926-33
15728504
J Bacteriol. 2009 Feb;191(3):832-43
19047354